Ligand · 960
960 · 1-[(6-chloroimidazo[1,2-b]pyridazin-3-yl)sulfonyl]-6-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,3-b]pyridine
960, 1-[(6-chloroimidazo[1,2-b]pyridazin-3-yl)sulfonyl]-6-(1-methyl-1H-pyrazol-4-yl)-1H-pyrazolo[4,3-b]pyridine (C16 H11 Cl N8 O2 S, 414.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- 960
- Formula
- C16 H11 Cl N8 O2 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
960 in 2 structures; the first of them:
- 5Z0S · Crystal structure of FGFR1 kinase domain in complex with a novel inhibitor · 960 A801 · binds LEU484, GLY485, PHE489, VAL492, ALA512, LYS514, GLU531, ILE545 and 10 more
- 5Z0S · Crystal structure of FGFR1 kinase domain in complex with a novel inhibitor · 960 A801 · binds LEU484, GLY485, PHE489, VAL492, ALA512, LYS514, ILE545, VAL561 and 9 more
Residues it binds most
ALA 4, ASN 4, LEU 4, VAL 4, GLU 4, ARG 4, ASP 4, GLY 4, ILE 4, LYS 4 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.